Clinical trial
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor…
NCT00075478 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00075478 |
|---|---|
| Title | Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer |
| Official title | A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH National Cancer Institute (NCI) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Diffuse Large B-Cell Lymphoma, Hematopoietic and Lymphoid Cell Neoplasm, Indolent Non-Hodgkin Lymphoma, Mantle Cell Lymphoma, Myelodysplastic/Myeloproliferative Neoplasm and 4 more |
| Intervention type | Drug, Procedure |
| Interventions | Total-Body Irradiation, Fludarabine Phosphate, Mycophenolate Mofetil, Cyclosporine, Peripheral Blood Stem Cell Transplantation |
| Enrollment | 87 |
| Start date | Oct 1, 2003 |
| Primary completion | Feb 1, 2014 |
| Completion | Feb 2, 2014 |
| First posted | Jan 12, 2004 |
| Last update posted | May 15, 2017 |
| Countries | Germany, Italy, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: